Instil Bio Total Assets 2020-2021 | TIL

Instil Bio total assets from 2020 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
Instil Bio Annual Total Assets
(Millions of US $)
2020 $319
2019 $9
Instil Bio Quarterly Total Assets
(Millions of US $)
2021-09-30 $647
2021-06-30 $673
2021-03-31 $696
2020-12-31 $319
2020-09-30 $0
2020-06-30 $0
2020-03-31 $0
2019-12-31 $9
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.786B $0.000B
Instil Bio Inc. is a clinical-stage biopharmaceutical company. It is focused on developing an innovative cell therapy pipeline of autologous TIL therapies for the treatment of patients with cancer. Instil Bio Inc. is based in DALLAS.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $144.122B 9.11
Bio-Rad Laboratories (BIO.B) United States $18.677B 37.90
QIAGEN (QGEN) Netherlands $11.053B 18.72
Biohaven Pharmaceutical Holding (BHVN) United States $8.002B 0.00
Emergent Biosolutions (EBS) United States $2.809B 10.10
Arcus Biosciences (RCUS) United States $2.516B 0.00
Myovant Sciences (MYOV) United Kingdom $1.432B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.186B 0.00
Zymeworks (ZYME) Canada $0.697B 0.00
Ambrx Biopharma (AMAM) United States $0.230B 0.00
SQZ Biotechnologies (SQZ) United States $0.229B 0.00
Enzo Biochem (ENZ) United States $0.160B 20.69